159 related articles for article (PubMed ID: 21265736)
1. Role of the interface between the FMN and FAD domains in the control of redox potential and electronic transfer of NADPH-cytochrome P450 reductase.
Aigrain L; Pompon D; Truan G
Biochem J; 2011 Apr; 435(1):197-206. PubMed ID: 21265736
[TBL] [Abstract][Full Text] [Related]
2. The closed and compact domain organization of the 70-kDa human cytochrome P450 reductase in its oxidized state as revealed by NMR.
Vincent B; Morellet N; Fatemi F; Aigrain L; Truan G; Guittet E; Lescop E
J Mol Biol; 2012 Jul; 420(4-5):296-309. PubMed ID: 22543241
[TBL] [Abstract][Full Text] [Related]
3. Determination of the redox properties of human NADPH-cytochrome P450 reductase.
Munro AW; Noble MA; Robledo L; Daff SN; Chapman SK
Biochemistry; 2001 Feb; 40(7):1956-63. PubMed ID: 11329262
[TBL] [Abstract][Full Text] [Related]
4. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
Gutierrez A; Lian LY; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2001 Feb; 40(7):1964-75. PubMed ID: 11329263
[TBL] [Abstract][Full Text] [Related]
5. Proximal FAD histidine residue influences interflavin electron transfer in cytochrome P450 reductase and methionine synthase reductase.
Meints CE; Parke SM; Wolthers KR
Arch Biochem Biophys; 2014 Apr; 547():18-26. PubMed ID: 24589657
[TBL] [Abstract][Full Text] [Related]
6. Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding.
Gutierrez A; Paine M; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2002 Apr; 41(14):4626-37. PubMed ID: 11926825
[TBL] [Abstract][Full Text] [Related]
7. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase.
Yamamoto K; Kimura S; Shiro Y; Iyanagi T
Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330
[TBL] [Abstract][Full Text] [Related]
8. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of the cytochrome P450 reductase-cytochrome
Freeman SL; Martel A; Devos JM; Basran J; Raven EL; Roberts GCK
J Biol Chem; 2018 Apr; 293(14):5210-5219. PubMed ID: 29475945
[TBL] [Abstract][Full Text] [Related]
10. Coupling of Redox and Structural States in Cytochrome P450 Reductase Studied by Molecular Dynamics Simulation.
Iijima M; Ohnuki J; Sato T; Sugishima M; Takano M
Sci Rep; 2019 Jun; 9(1):9341. PubMed ID: 31249341
[TBL] [Abstract][Full Text] [Related]
11. Interflavin electron transfer in human cytochrome P450 reductase is enhanced by coenzyme binding. Relaxation kinetic studies with coenzyme analogues.
Gutierrez A; Munro AW; Grunau A; Wolf CR; Scrutton NS; Roberts GC
Eur J Biochem; 2003 Jun; 270(12):2612-21. PubMed ID: 12787027
[TBL] [Abstract][Full Text] [Related]
12. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
Sevrioukova I; Truan G; Peterson JA
Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
[TBL] [Abstract][Full Text] [Related]
13. Structure of the open conformation of a functional chimeric NADPH cytochrome P450 reductase.
Aigrain L; Pompon D; Moréra S; Truan G
EMBO Rep; 2009 Jul; 10(7):742-7. PubMed ID: 19483672
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the FAD binding domain of cytochrome P450 reductase.
Hodgson AV; Strobel HW
Arch Biochem Biophys; 1996 Jan; 325(1):99-106. PubMed ID: 8554349
[TBL] [Abstract][Full Text] [Related]
16. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
Jin Y; Chen M; Penning TM; Miller WL
Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
[TBL] [Abstract][Full Text] [Related]
17. Short-lived neutral FMN and FAD semiquinones are transient intermediates in cryo-reduced yeast NADPH-cytochrome P450 reductase.
Davydov RM; Jennings G; Hoffman BM; Podust LM
Arch Biochem Biophys; 2019 Sep; 673():108080. PubMed ID: 31445894
[TBL] [Abstract][Full Text] [Related]
18. Determination of the redox potentials and electron transfer properties of the FAD- and FMN-binding domains of the human oxidoreductase NR1.
Finn RD; Basran J; Roitel O; Wolf CR; Munro AW; Paine MJ; Scrutton NS
Eur J Biochem; 2003 Mar; 270(6):1164-75. PubMed ID: 12631275
[TBL] [Abstract][Full Text] [Related]
19. A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases.
Lamb DC; Kim Y; Yermalitskaya LV; Yermalitsky VN; Lepesheva GI; Kelly SL; Waterman MR; Podust LM
Structure; 2006 Jan; 14(1):51-61. PubMed ID: 16407065
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the cytochrome P450 reductase redox potential by the phospholipid bilayer.
Das A; Sligar SG
Biochemistry; 2009 Dec; 48(51):12104-12. PubMed ID: 19908820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
